Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Oric Pharmaceuticals
ORIC
$1.17B
| $194K | ﹤0.01% |
27,490
-106,416
| -79% | -$953K |
|
3727
Lifestance Health
LFST
$4.15B
| $194K | ﹤0.01% |
39,492
+20,885
| +112% | +$126K |
|
3728
First Mid Bancshares
FMBH
$1.4B
| $193K | ﹤0.01% |
5,882
+1,145
| +24% | +$36K |
|
3729
Azenta
AZTA
$1.3B
| $193K | ﹤0.01% |
3,669
-15,615
| -81% | -$834K |
|
3730
Methanex
MEOH
$4.23B
| $193K | ﹤0.01% |
3,997
+462
| +13% | +$23K |
|
3731
Quanterix
QTRX
$159M
| $193K | ﹤0.01% |
14,595
+1,882
| +15% | +$31.5K |
|
3732
JPMorgan US Quality Factor ETF
JQUA
$8.14B
| $192K | ﹤0.01% |
+3,618
| New | +$187K |
|
3733
Oil-Dri
ODC
$1.43B
| $191K | ﹤0.01% |
5,964
+626
| +12% | +$23K |
|
|
GLDD
3734
DELISTED
Great Lakes Dredge & Dock
GLDD
| $190K | ﹤0.01% |
21,645
+2,920
| +16% | +$24.8K |
|
3735
The RMR Group
RMR
$335M
| $190K | ﹤0.01% |
8,408
+1,149
| +16% | +$26.9K |
|
3736
Janus Henderson Short Duration Income ETF
VNLA
$3.34B
| $190K | ﹤0.01% |
3,906
-63
| -2% | -$3.05K |
|
3737
Sable Offshore Corp
SOC
$836M
| $190K | ﹤0.01% |
12,581
-15,973
| -56% | -$201K |
|
3738
CALL
SolarEdge
SEDG
$2.37B
| $189K | ﹤0.01% |
7,500
| – | – |
|
3739
Tango Therapeutics
TNGX
$4.21B
| $189K | ﹤0.01% |
22,065
-169,368
| -88% | -$1.31M |
|
3740
Relmada Therapeutics
RLMD
$540M
| $189K | ﹤0.01% |
62,951
-60,862
| -49% | -$220K |
|
3741
Pliant Therapeutics
PLRX
$65M
| $189K | ﹤0.01% |
17,549
-195,756
| -92% | -$2.52M |
|
3742
Preformed Line Products
PLPC
$1.39B
| $187K | ﹤0.01% |
1,505
+180
| +14% | +$23K |
|
|
SACH
3743
Sachem Capital Corp
SACH
$37.1M
| $187K | ﹤0.01% |
72,245
-182,306
| -72% | -$564K |
|
3744
Stagwell
STGW
$2B
| $187K | ﹤0.01% |
27,425
+4,150
| +18% | +$26.8K |
|
|
DFTX
3745
Definium Therapeutics
DFTX
$5.6B
| $187K | ﹤0.01% |
25,905
-85,161
| -77% | -$745K |
|
3746
Global Industrial
GIC
$1.38B
| $187K | ﹤0.01% |
5,950
+479
| +9% | +$17.6K |
|
|
NPKI
3747
NPK International
NPKI
$1.02B
| $187K | ﹤0.01% |
22,443
+7,037
| +46% | +$54.2K |
|
|
WMPN
3748
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $186K | ﹤0.01% |
16,326
-5,894
| -27% | -$70.9K |
|
3749
Perella Weinberg Partners
PWP
$1.08B
| $186K | ﹤0.01% |
11,439
+2,337
| +26% | +$35.3K |
|
3750
BlackRock Debt Strategies Fund
DSU
$592M
| $186K | ﹤0.01% |
17,122
| – | – |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.